Haemophilia Flashcards

1
Q

when assessing bleeding disorders, what are some important features on history?

A

previous response to haemostatic challenges (such as surgery)

family history?

drug history?

type of bleeding - joint, spont, mucosal?

age when bleeding started?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is ecarin time?

A

this is a test to determine whether a prolonged PT is due to Vitamin K deficiency or liver disease (leading to generalised factor deficiency)

Ecarin is the same as Echis time and is named for the Echis snake, whose venom is used for the test.

In this test, the venom activates prothrombin (to thrombin) without vitamin K.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. What is a reptilase time (RT) and how is it used?
A

If heparin is suspected as the cause of a prolonged thrombin time (TT), heparin assays or reptilase time (RT) can be used to confirm heparin presence. RT measures the time it takes for a clot to form after reptilase has been added to plasma. TT may be ordered with an RT to investigate a prolonged clotting time.

Since TT, but not RT, is affected by the anticoagulant heparin, prolongation of both TT and RT indicates decreased fibrinogen level and/or abnormal function of fibrinogen. If TT is prolonged but RT is normal, heparin contamination is likely the cause.

The clotting-based functional fibrinogen assay is now routinely available in clinical laboratories and has largely replaced the need for TT and RT for evaluation of fibrinogen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the assays that can be used in the NOACs?

A

With the direct-IIa inhibitors
(dabigatran - note the ending T-ran - the T stands for thrombin (in the naming convention))
————————-

Ecarin Clotting Time is the best, and can be used to quantitatively measure the activity.

PT is relatively insensitive, APTT is relatively SENSITIVE.

Thrombin time is TOO SENS

The Xa-inhibitors (ravaroXaBAN and apiXaBAN (note the Xa BAN suffix to identify Xa binding))

PT is SENS at high concentration
APTT is relatively INSENS
TT is not useful
ECT is not useful

Anti-Xa is the best, and how we quantitatively measure the effect of the drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is senile purpura?

A

this is the process whereby vessels get very rigid and friable. they are easily damaged and can cause purpura.

not related to coagulation or platelet disorder (although can always have co-existant disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What factor level is altered when vWF level is altered?

A

plasma vWF carries factor VIII around the body, to prevent it from being broken down.

this means that with vWD you can get a prolonged APTT.

(but it is often only a small decrease in FVIII, and so the APTT can be normal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what sort of bleeding patterns do we get with vWD? (what surfaces)

A

it tends to be mucosal surfaces, such as epistaxis and menorrhagia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the 3 types of vWD?

A

type 1: partial quantitative deficiency (decreased level and therefore functional ability)

type 2: qualitative - normal level, but works badly

type 3: severe deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

if you have a female with low factor VIII, what is a possible cause?

A

there is a subtype of vWD, type 2N, which has normal vWF but decreased binding of factor VIII!

isn’t that ridic!?

basically, you see a woman with haemophilia A, but that can’t be, because it’s X-linked. so then you should think of this ridiculousness…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what sort of test do we do to prove vWD?

A

we use a VWF:Ag which binds vWF and tells us the amount.

On a separate vial, we then use a VWF:RCo which binds vWF and tells us the function of the vWF

finally we check the level of factor VIII

if the total level of vWF is very low, then we have type 3

if the vWF:RCo is significantly higher than the vWF:Ag level, then the function is okay, but the level is low –> this is type 1!

if the vWF:RCo (functional assay) is much lower than the vWF:Ag, then this is type 2!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the levels of factor with different severities of haemophilia?

A

normal range of clotting factors is wide, from 50 - 150%

mild haemophilia is 5 - 49% of normal levels

moderate is 1 - 5% (this has to occur with trauma, even if it is very minor)

severe is <1% (this is associated with spontaneous bleed)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what do we use for haemophilia A and B?

A

synthetically derived factor VIII and IX

if the patient has inhibitors, then we have to by-pass those, and give factor VII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What do we use for VWF?

A

for milder cases of VWF or mild haemophilia A, DDAVP causes an acute release of VWF and FVIII

if the patient needs factor VIII we have to use plasma derived concentrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

why would you use tranexamic acid in a haemophilia or VWD case?

A

tranexamic acid is an anti-fibrinolytic.

that is, it works against fibrinolysis.

that is, it stabilises clot

So, it can be used after surgery or bleeding to help the body heal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

why do haemophiliacs get inhibitors?

how common is it?

A

if the patient has very low titres of a factor, then the body isn’t familiar with them. as such, with repeated administrations, the body creates antibodies to these factors.

the risk in severe Haemophilia A is about 30%

Haem B is less common (1-2%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the consequences for treatment of severe haemophilia A with inhibitors?

A

this becomes very difficult, because prophylactic treatment is less feasible.

instead the patients have a greater risk of spontaneous bleeding (after treatment initiation)

17
Q

what are the major types of inherited platelet dysfunction disorders?

A

The first type is abnormal receptors.

e.g. Glanzmann thrombasthenia, which is AR and has abnormal alpha2bBeta3 receptor complex

the second type are the storage pool disorder, which have a deficiency of the granules

e. g. Hermansky-Pudlak or Chediak-Higashi
- it becomes tricky because the platelet function tests are often normal, and you need to do a test of platelet nucleotide levels.

18
Q

what does the platelet-100 tests provide?

A

this is a strange lab test where they firstly push blood through a tiny orifice and measure the time to clot.

then they do it in a setting with ADP, and this mimics aspirin therapy.

19
Q

what is the most common type of bleeding in patients with Haemophilia A with 8% baseline factor VIII?

a. spont purpura
b. spont GI bleed
c. spont deep muscle bleed
d. spont haemarthroses
e. no spont bleed

A

the answer is E.

there is no spontaneous bleeding in patients with mild (factor level 5 - 49%) haemophilia

even in moderate, there should be no spontaneous bleeding (it should be after minor trauma or procedures)

20
Q

In haemophilia treatment, how do we estimate what should happen to the post treatment factor levels?

(based on the dose we give)

A

If we give 25U/kg, the expected rise is 50%

If we give 30U/kg (which doesn’t happen), the expected rise is 60%

basically double the dosing to estimate the increase.

21
Q

During haemostasis, which is the primary binding site of vWF to platelets?

what is the site of platelet-platelet aggregation?

A

The initiation is via the platelet glycoprotein Ib-IX-V

the platelet-platelet cascade is the platelet glycoprotein IIb-IIIa